单孔与多孔腹腔镜结肠癌手术短期结局:SIMPLE多中心随机临床试验
这项在韩国7个中心开展的非劣效性随机对照试验纳入388例临床I-III期升结肠或乙状结肠腺癌成人患者,比较单孔与多孔腹腔镜手术的短期结局。主要终点30天术后并发症率单孔组为10.6%、多孔组为13.9%(95%CI -10.05至3.05个百分点,P<0.0001),单孔组总切口长度更短(4.6 cm vs 7.2 cm,P<0.001),结论为单孔不劣于多孔。
要点
- 单孔腹腔镜结肠癌手术30天并发症率非劣效于多孔腹腔镜。
- 单孔组总切口长度更短,标本取出切口长度两组无差异。
- 在经验丰富术者操作下,单孔可作为特定患者的手术选择。
核心结论
- 单孔腹腔镜结肠癌手术虽无明显优于多孔腹腔镜,但数据提示其不劣于多孔腹腔镜。
- 在经验丰富术者操作下,单孔腹腔镜可考虑作为特定患者的手术选择。
研究设计与样本
- 多中心、前瞻性、随机对照试验,采用非劣效性设计。
- 2011年8月至2017年6月在韩国7个中心开展,共纳入388例19-85岁临床I、II或III期升结肠或乙状结肠腺癌成人患者并随机分组。
- 主要终点为30天术后并发症率,次要终点包括清扫淋巴结数、切缘长度、术后疼痛及功能恢复时间(肠蠕动和饮食),术后随访30天。
主要发现
- 388例中359例(92.5%)完成研究(单孔组n=179,多孔组n=180)。
- 30天术后并发症率单孔组为10.6%,多孔组为13.9%(95%CI -10.05至3.05个百分点,P<0.0001)。
- 单孔组总切口长度短于多孔组(4.6 cm vs 7.2 cm,P<0.001),标本取出部位长度两组无差异(4.4 cm vs 4.6 cm,P=0.249)。
- 两组所有次要终点及其他结局均无显著差异。
临床怎么用
- 对于临床I-III期升结肠或乙状结肠腺癌的特定患者,经验丰富术者可考虑选择单孔腹腔镜手术。
- 单孔腹腔镜手术可作为多孔腹腔镜之外的术式选项,不以短期并发症优势为主要决策依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare short-term perioperative outcomes of single-port laparoscopic surgery (SPLS) and multiport laparoscopic surgery (MPLS) for colon cancer. SUMMARY BACKGROUND DATA: Although many studies reported short- and long-term outcomes of SPLS for colon cancer compared with MPLS, few have reported results of randomized controlled trials. METHODS: This was a multicenter, prospective, randomized controlled trial with a noninferiority design. It was conducted between August 2011 and June 2017 at 7 sites in Korea. A total of 388 adults (aged 19-85 yrs) with clinical stage I, II, or III adenocarcinoma of the ascending or sigmoid colon were enrolled and randomized. The primary endpoint was 30-day postoperative complication rates. Secondary endpoints were the number of harvested lymph nodes, length of the resection margin, postoperative pain, and time to functional recovery (bowel movement and diet). Patients were followed for 30 days after surgery. RESULTS: Among 388 patients, 359 (92.5%) completed the study (SPLS, n = 179; MPLS, n = 180). The 30-day postoperative complication rate was 10.6% in the SPLS group and 13.9% in the MPLS group (95% confidence interval, -10.05 to 3.05 percentage points; P < 0.0001). Total incision length was shorter in the SPLS group than in the MPLS group (4.6 cm vs 7.2 cm, P < 0.001), whereas the length of the specimen extraction site did not differ (4.4 cm vs 4.6 cm, P = 0.249). There were no significant differences between groups for all secondary endpoints and all other outcomes. CONCLUSIONS: Even though there was no obvious benefit to SPLS over MPLS when performing colectomy for cancer, our data suggest that SPLS is noninferior to MPLS and can be considered an option in selected patients, when performed by experienced surgeons.Trial registration: ClinicalTrials.gov Identifier: NCT01480128.
引用
- Lee YS, Kim JH, Kim HJ, et al. Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial. Ann Surg. 2021. PMID: 32209897. doi:10.1097/SLA.0000000000003882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。